SaumilGandhiMDPhD

Radiation Oncology • Houston, TX

Assistant Professor, University of Texas MD Anderson Cancer Center

Join to view full profile

Dr. Gandhi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gandhi's full profile

Already have an account?

Office
1515 Holcombe Blvd
Unit 97
Houston, TX 77030
Phone+1 713-563-7775

Education & Training

University of Pennsylvania Health SystemResidency, Radiation Oncology, 2012 - 2016
University of Pennsylvania Health SystemResidency, Internal Medicine, 2011 - 2012
Albert Einstein College of MedicineClass of 2011

Certifications & Licensure

FL State Medical License 2021 - Present
TX State Medical License 2016 - 2026
OK State Medical License 2020 - 2021
PA State Medical License 2011 - 2016
American Board of Radiology Radiation Oncology

Clinical Trials

Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies Start of enrollment: 2023 May 08
Recruiting
Phase 1, Phase 2
Roles: Principal Investigator, Contact
NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer Start of enrollment: 2021 Feb 10
Recruiting
Phase 1
Roles: Principal Investigator, Contact
Feasibility, Safety, and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Central Lung Tumors Start of enrollment: 2022 Nov 17
Recruiting
Not Applicable
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in Nonsmall Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospe...
Felipe Soto-Lanza, Lydia Glick, Colin Chan, Linda Zhong, Nathaniel Wilson
Clinical Lung Cancer. 2024-11-01
Superior antitumor immune response achieved with proton over photon immunoradiotherapy is amplified by the nanoradioenhancer NBTXR3.
Yun Hu, Sébastien Paris, Narayan Sahoo, Qi Wang, Qianxia Wang
Journal of Nanobiotechnology. 2024-10-01
Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable local...
Kelsey L Corrigan, Ting Xu, Yuki Sasaki, Ruitao Lin, Aileen B Chen
Radiotherapy and Oncology. 2024-04-01

Journal Articles

Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?☆
Zhongxing Liao, Saumil J Gandhi, Steven H Lin, ScienceDirect

Press Mentions

Updates in EGFR-Mutated Oligometastatic NSCLCJune 14th, 2023